Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 12.


Perna, Daniele, Karreth, Florian A, Rust, Alistair G, Perez-Mancera, Pedro A, Rashid, Mamunur, Iorio, Francesco, Alifrangis, Constantine, Arends, Mark J, Bosenberg, Marcus W, Bollag, Gideon
et al (show 2 more authors) (2015) BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model. Proceedings of the National Academy of Sciences of the United States of America, 112 (6). E536-E545.


Gupta, Priyanka, Totti, Stella, Perez-Mancera, Pedro A, Dyke, Eleanor, Nisbet, Andrew, Schettino, Giuseppe, Webb, Roger and Velliou, Eirini G
(2019) Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model. RSC ADVANCES, 9 (71). pp. 41649-41663.


Barrera, Lawrence N, Evans, Anthony ORCID: 0000-0001-8547-1730, Lane, Brian, Brumskill, Sarah, Oldfield, Frances E, Campbell, Fiona, Andrews, Timothy, Lu, Zipeng, Perez-Mancera, Pedro A, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404
et al (show 10 more authors) (2020) Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties. Cancer Research, 80 (13). pp. 2861-2873.


Wong, Jasmine C, Perez-Mancera, Pedro A, Huang, Tannie Q, Kim, Jangkyung, Grego-Bessa, Joaquim, Alzamora, Maria del Pilar, Kogan, Scott C, Sharir, Amnon, Keefe, Susan H, Morales, Carolina E
et al (show 10 more authors) (2020) Kras<SUP>P34R</SUP> and Kras<SUP>T58I</SUP> mutations induce distinct RASopathy phenotypes in mice. JCI INSIGHT, 5 (21). 140495-.


Gupta, Priyanka, Perez-Mancera, Pedro A, Kocher, Hemant, Nisbet, Andrew, Schettino, Giuseppe and Velliou, Eirini G
(2020) A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the <i>in vivo</i> Tumor Microenvironment. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 8. 290-.


Humpton, Timothy J, Alagesan, Brinda, DeNicola, Gina M, Lu, Dan, Yordanov, Georgi N, Leonhardt, Carl S, Yao, Melissa A, Alagesan, Priya, Zaatari, Maya N, Park, Youngkyu
et al (show 7 more authors) (2019) Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer. CANCER DISCOVERY, 9 (9). pp. 1268-1287.


Kirschner, Kristina, Samarajiwa, Shamith A, Cairns, Jonathan M, Menon, Suraj, Perez-Mancera, Pedro A, Tomimatsu, Kosuke, Bermejo-Rodriguez, Camino ORCID: 0000-0002-7554-1640, Ito, Yoko, Chandra, Tamir, Narita, Masako
et al (show 6 more authors) (2015) Phenotype Specific Analyses Reveal Distinct Regulatory Mechanism for Chronically Activated p53. PLOS GENETICS, 11 (3). e1005053-.


Evers, Lisa, Perez-Mancera, Pedro A, Lenkiewicz, Elizabeth, Tang, Nanyun, Aust, Daniela, Knoesel, Thomas, Ruemmele, Petra, Holley, Tara, Kassner, Michelle, Aziz, Meraj
et al (show 5 more authors) (2014) STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma. GENOME MEDICINE, 6 (1). 9-.


Poulin, Emily J, Bera, Asim K, Lu, Jia, Lin, Yi-Jang, Strasser, Samantha Dale, Paulo, Joao A, Huang, Tannie Q, Morales, Carolina, Yana, Wei, Cook, Joshua
et al (show 19 more authors) (2019) Tissue-Specific Oncogenic Activity of KRAS<SUP>A</SUP><SUP>146</SUP><SUP>T</SUP>. CANCER DISCOVERY, 9 (6). pp. 738-755.


Cassidy, Liam D, Young, Andrew RJ, Perez-Mancera, Pedro A, Nimmervoll, Birgit, Jaulim, Adil, Chen, Hung-Chang, McIntyre, Dominick JO, Brais, Rebecca, Ricketts, Thomas, Pacey, Simon
et al (show 4 more authors) (2018) A novel Atg5-shRNA mouse model enables temporal control of Autophagy in vivo. Autophagy, 14 (7). pp. 1256-1266.


Barrera, Lawrence N, Ridley, P Matthew ORCID: 0000-0001-9642-2483, Bermejo-Rodriguez, Camino ORCID: 0000-0002-7554-1640, Costello, Eithne and Perez-Mancera, Pedro A
(2023) The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 79 (1). pp. 193-204.


Wong, Jasmine C, Perez-Mancera, Pedro A, Kim, Jangkyung, Jen, Kuang-Yu, Kogan, Scott C, Firestone, Ari J, Collisson, Eric A, Tuveson, David A and Shannon, Kevin
(2020) A second site <i>Kras<SUP>G12D</SUP></i> mutation that impairs PI3K binding rescues embryonic lethality, abrogates myeloproliferative disease, and delays lung tumorigenesis. .

This list was generated on Sun Feb 11 02:53:01 2024 GMT.